| Bioactivity | Rifamycin B is a member of ansamycin antibiotics family with an anti-mycobacterial activity against tuberculosis, leprosy and AIDS-related mycobacterial infections. Rifamycin B is a metabolic product of Nocardia inediterranei, which can yield rifamycin O and rifamycin S by microbial transformation[1][2]. |
| CAS | 13929-35-6 |
| Formula | C39H49NO14 |
| Molar Mass | 755.80 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Seong BL, et al. Microbial transformation of rifamycin B: a new synthetic approach to rifamycin derivatives. J Antibiot (Tokyo). 1983 Oct;36(10):1402-4. [2]. Jin ZH, et al. Scale-up of rifamycin B fermentation with Amycolatoposis mediterranei. J Zhejiang Univ Sci. 2004 Dec;5(12):1590-6. |
Rifamycin B
CAS: 13929-35-6 F: C39H49NO14 W: 755.80
Rifamycin B is a member of ansamycin antibiotics family with an anti-mycobacterial activity against tuberculosis, lepros
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.